The PCBP1 gene encoding poly(rc) binding protein i is recurrently mutated in Burkitt lymphoma. Issue 9 (14th July 2015)
- Record Type:
- Journal Article
- Title:
- The PCBP1 gene encoding poly(rc) binding protein i is recurrently mutated in Burkitt lymphoma. Issue 9 (14th July 2015)
- Main Title:
- The PCBP1 gene encoding poly(rc) binding protein i is recurrently mutated in Burkitt lymphoma
- Authors:
- Wagener, Rabea
Aukema, Sietse M.
Schlesner, Matthias
Haake, Andrea
Burkhardt, Birgit
Claviez, Alexander
Drexler, Hans G.
Hummel, Michael
Kreuz, Markus
Loeffler, Markus
Rosolowski, Maciej
López, Cristina
Möller, Peter
Richter, Julia
Rohde, Marius
Betts, Matthew J.
Russell, Robert B.
Bernhart, Stephan H.
Hoffmann, Steve
Rosenstiel, Philip
Schilhabel, Markus
Szczepanowski, Monika
Trümper, Lorenz
Klapper, Wolfram
Siebert, Reiner
on behalf of the ICGC MMML‐Seq‐Project and the "Molecular Mechanisms in Malignant Lymphomas" Network Project of the Deutsche Krebshilfe - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The genetic hallmark of Burkitt lymphoma is the translocation t(8;14)(q24;q32), or one of its light chain variants, resulting in <italic>IG</italic>‐<italic>MYC</italic> juxtaposition. However, these translocations alone are insufficient to drive lymphomagenesis, which requires additional genetic changes for malignant transformation. Recent studies of Burkitt lymphoma using next generation sequencing approaches have identified various recurrently mutated genes including <italic>ID3, TCF3, CCND3</italic>, and <italic>TP53</italic>. Here, by using similar approaches, we show that <italic>PCBP1</italic> is a recurrently mutated gene in Burkitt lymphoma. By whole‐genome sequencing, we identified somatic mutations in <italic>PCBP1</italic> in 3/17 (18%) Burkitt lymphomas. We confirmed the recurrence of <italic>PCBP1</italic> mutations by Sanger sequencing in an independent validation cohort, finding mutations in 3/28 (11%) Burkitt lymphomas and in 6/16 (38%) Burkitt lymphoma cell lines. <italic>PCBP1</italic> is an intron‐less gene encoding the 356 amino acid poly(rC) binding protein 1, which contains three K‐Homology (KH) domains and two nuclear localization signals. The mutations predominantly (10/12, 83%) affect the KH III domain, either by complete domain loss or amino acid changes. Thus, these changes are predicted to alter the various functions of PCBP1, including nuclear trafficking<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The genetic hallmark of Burkitt lymphoma is the translocation t(8;14)(q24;q32), or one of its light chain variants, resulting in <italic>IG</italic>‐<italic>MYC</italic> juxtaposition. However, these translocations alone are insufficient to drive lymphomagenesis, which requires additional genetic changes for malignant transformation. Recent studies of Burkitt lymphoma using next generation sequencing approaches have identified various recurrently mutated genes including <italic>ID3, TCF3, CCND3</italic>, and <italic>TP53</italic>. Here, by using similar approaches, we show that <italic>PCBP1</italic> is a recurrently mutated gene in Burkitt lymphoma. By whole‐genome sequencing, we identified somatic mutations in <italic>PCBP1</italic> in 3/17 (18%) Burkitt lymphomas. We confirmed the recurrence of <italic>PCBP1</italic> mutations by Sanger sequencing in an independent validation cohort, finding mutations in 3/28 (11%) Burkitt lymphomas and in 6/16 (38%) Burkitt lymphoma cell lines. <italic>PCBP1</italic> is an intron‐less gene encoding the 356 amino acid poly(rC) binding protein 1, which contains three K‐Homology (KH) domains and two nuclear localization signals. The mutations predominantly (10/12, 83%) affect the KH III domain, either by complete domain loss or amino acid changes. Thus, these changes are predicted to alter the various functions of PCBP1, including nuclear trafficking and pre‐mRNA splicing. Remarkably, all six primary Burkitt lymphomas with a <italic>PCBP1</italic> mutation expressed MUM1/IRF4, which is otherwise detected in around 20–40% of Burkitt lymphomas. We conclude that <italic>PCBP1</italic> mutations are recurrent in Burkitt lymphomas and might contribute, in cooperation with other mutations, to its pathogenesis. © 2015 Wiley Periodicals, Inc.</p> </abstract> … (more)
- Is Part Of:
- Genes, chromosomes & cancer. Volume 54:Issue 9(2015:Sep.)
- Journal:
- Genes, chromosomes & cancer
- Issue:
- Volume 54:Issue 9(2015:Sep.)
- Issue Display:
- Volume 54, Issue 9 (2015)
- Year:
- 2015
- Volume:
- 54
- Issue:
- 9
- Issue Sort Value:
- 2015-0054-0009-0000
- Page Start:
- 555
- Page End:
- 564
- Publication Date:
- 2015-07-14
- Subjects:
- Cancer -- Genetic aspects -- Periodicals
616.994042 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2264 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/gcc.22268 ↗
- Languages:
- English
- ISSNs:
- 1045-2257
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4111.763000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4395.xml